Welch Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-345
| Closed | -$220K | – | 288 |
|
|
2025
Q1 | $220K | Sell |
345
-23
| -6% | -$14.7K | 0.01% | 235 |
|
|
2024
Q4 | $259K | Buy |
368
+8
| +2% | +$5.62K | 0.01% | 221 |
|
|
2024
Q3 | $378K | Buy |
360
+150
| +71% | +$158K | 0.02% | 176 |
|
|
2024
Q2 | $221K | Sell |
210
-203
| -49% | -$213K | 0.01% | 233 |
|
|
2024
Q1 | $398K | Buy |
413
+3
| +0.7% | +$2.89K | 0.02% | 145 |
|
|
2023
Q4 | $360K | Buy |
410
+140
| +52% | +$123K | 0.02% | 157 |
|
|
2023
Q3 | $222K | Buy |
+270
| New | +$222K | 0.01% | 191 |
|